Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    1658941 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation Study
Conditions: Osteoporosis;   Humoral Hypercalcemia of Malignancy;   Hyperparathyroidism
Intervention: Drug: Parathyroid Hormone-related Protein (1-36)
2 Completed 7 Day Continuous Parathyroid Hormone IV Infusion
Conditions: Osteoporosis;   Bone Diseases, Endocrine;   Hyperparathyroidism
Intervention: Drug: parathyroid hormone (1-34)

Indicates status has not been verified in more than two years